Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$8.63 - $12.53 $50,770 - $73,713
5,883 New
5,883 $62,000
Q2 2022

Aug 15, 2022

BUY
$8.45 - $14.84 $108,405 - $190,382
12,829 New
12,829 $179,000
Q3 2021

Nov 12, 2021

SELL
$25.71 - $35.24 $635,756 - $871,414
-24,728 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$30.1 - $34.85 $145,413 - $168,360
-4,831 Reduced 16.34%
24,728 $771,000
Q1 2021

Apr 29, 2021

BUY
$25.89 - $44.46 $568,596 - $976,430
21,962 Added 289.09%
29,559 $907,000
Q4 2020

Jan 21, 2021

BUY
$23.42 - $39.5 $177,921 - $300,081
7,597 New
7,597 $261,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $57.9M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Hershey Trust CO Portfolio

Follow Hershey Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hershey Trust CO with notifications on news.